Covid-19: Anti-TNF drug adalimumab to be trialled for patients in the community
Elisabeth Mahase
Abstract
Covid-19: Anti-TNF drug adalimumab to be trialled for patients in the community
Topics & Concepts
AdalimumabWorld Wide WebVisitor patternCoronavirus disease 2019 (COVID-19)Internet privacyMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Computer scienceTumor necrosis factor alphaInternal medicineProgramming languageDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research